Pladevall M, Riera-Guardia N, Margulis AV, Varas-Lorenzo C, Calingaert B, Perez-Gutthann S. Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies. BMC Cardiovasc Disord. 2016 Jan 15;16:14. doi: 10.1186/s12872-016-0187-5. (open access)

Smits MM, Muskiet MHA, Tonneijck L, Hoekstra T, Kramer MHH, Diamant M, van Raalte DH. Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males. Br J Clin Pharmacol  DOI: 10.1111/bcp.12843

Muskiet MHA, Tonneijck L, Smits MM, Kramer MHH, Diamant M, Joles JA, van Raalte DH. Acute renal haemodynamic effects of GLP-1 receptor agonist exenatide in healthy overweight males. Diabetes Obes Metab DOI: 10.1111/dom.12601

Smits MM, Tonneijck L, Muskiet MHA, Hoekstra T, Kramer MHH, Pieters-van den Bos IC, Cahen, DL, Diamant M, Diamant M, van Raalte DH. Study Protocol: Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and long-term, randomised, placebo-controlled, double-blind, mechanistic intervention trial. BMJ Open 2015;5:e009579

Smits MM, Muskiet MH, Tonneijck L, Kramer MH, Diamant M, van Raalte DH, Serné EH. GLP-1 Receptor Agonist Exenatide Increases Capillary Perfusion Independent of Nitric Oxide in Healthy Overweight Men. Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1538-43. doi: 10.1161/ATVBAHA.115.305447. Epub 2015 Apr 23. PubMed PMID: 25908765.

Haluzík M, Mráz M, Svačina Š. Balancing benefits and risks in patients receiving incretin-based therapies: focus on cardiovascular and pancreatic side effects. Drug Saf. 2014 Dec;37(12):1003-10. doi: 10.1007/s40264-014-0238-8. PubMed PMID: 25391858.

Margulis AV, Pladevall M, Riera-Guardia N, Varas-Lorenzo C, Hazell L, Berkman ND, Viswanathan M, Perez-Gutthann S. Quality assessment of observational studies in a drug safety systematic review comparison of two tools: the Newcastle Ottawa Scale and the RTI item bank. Clin Epidemiol. 2014 Oct 10;6:359-68. doi: 10.2147/CLEP.S66677. eCollection 2014. PubMed PMID: 25336990(open access)
Varas-Lorenzo C, Margulis AV, Pladevall M, Riera-Guardia N, Calingaert B, Hazell L, Romio S, Perez-Gutthann S. The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studiesBMC Cardiovasc Disord. 2014 Sep 26;14:129. doi: 10.1186/1471-2261-14-129. PubMed PMID: 25260374; PubMed Central PMCID: PMC4246471. (open access)
Annual Meeting of the International Society of Pharmacovigilance (ISoP 2015, Prague)
International Conference on Pharmacoepidemiology 2015 (ICPE, Boston)
International Conference on Pharmacoepidemiology 2013 (ISPE, Montreal)
Workshop on Pancreatitis-Diabetes-Pancreatic Cancer 2013 (NIDKK-NCI, Bethesda)
Annual Meeting of the German Society of Epidemiology 2013 (DGEpi, Lepizig)